Mesenchymal stem cells modifications for enhanced bone targeting and bone regeneration.
Yuliya SafarovaBauyrzhan UmbayevGonzalo HortelanoSholpan AskarovaPublished in: Regenerative medicine (2020)
In pathological bone conditions (e.g., osteoporotic fractures or critical size bone defects), increasing the pool of osteoblast progenitor cells is a promising therapeutic approach to facilitate bone healing. Since mesenchymal stem cells (MSCs) give rise to the osteogenic lineage, a number of clinical trials investigated the potential of MSCs transplantation for bone regeneration. However, the engraftment of transplanted cells is often hindered by insufficient oxygen and nutrients supply and the tendency of MSCs to home to different sites of the body. In this review, we discuss various approaches of MSCs transplantation for bone regeneration including scaffold and hydrogel constructs, genetic modifications and surface engineering of the cell membrane aimed to improve homing and increase cell viability, proliferation and differentiation.
Keyphrases
- bone regeneration
- mesenchymal stem cells
- umbilical cord
- cell therapy
- bone marrow
- clinical trial
- bone mineral density
- drug delivery
- induced apoptosis
- signaling pathway
- randomized controlled trial
- stem cells
- cancer therapy
- cell proliferation
- risk assessment
- climate change
- oxidative stress
- postmenopausal women
- body composition
- open label
- mass spectrometry
- atomic force microscopy
- single molecule
- cell death
- study protocol
- bone loss
- human health